Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,166 GBX | -0.05% | -0.80% | +14.77% |
07:13pm | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
05:16pm | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 24TCr | |
+32.36% | 71TCr | |
+30.77% | 60TCr | |
-1.60% | 37TCr | |
+20.07% | 33TCr | |
+6.04% | 29TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.27% | 17TCr | |
+0.45% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Yongtai Technology Gets Approval to Market Rosuvastatin Chemical Raw Material in China